Synthesis, in vitro and in vivo antitumor and antiviral activity of novel 1-substituted benzimidazole derivatives

References

• Qian Y, Ling CQ. Preventive effect of Ganfujian granule on experimental hepatocarcinoma in rats. World J Gastroenterol 2004;10:755–7
   PubMed Web of Science ®Google Scholar
• Farazi PA, Depinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006;6:674–87
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225–49
   PubMed Web of Science ®Google Scholar
• Reh BD, Fajen JM. Worker exposures to nitrosamines in a rubber vehicle sealing plant. Am Ind Hyg Assoc J 1996;57:918–23
   PubMed Web of Science ®Google Scholar
• Bansal AK, Bansal M, Soni G, Bhatnagar D. Protective role of Vitamin E pre-treatment on N-nitrosodiethylamine induced oxidative stress in rat liver. Chem Biol Interact 2005;156:101–11
   PubMed Web of Science ®Google Scholar
• Sayed-Ahmed MM, Aleisa AM, Al-Rejaie SS, et al. Thymoquinone attenuates diethylnitrosamine induction of hepatic carcinogenesis through antioxidant signaling. Oxid Med Cell Longev 2010;3:254–61
   PubMed Web of Science ®Google Scholar
• Hsu PC, Buxton JA, Tu AW, et al. Publicly funded pegylated interferon-alpha treatment in British Columbia: disparities in treatment patterns for people with hepatitis C. Can J Gastroenterol 2008;22:359–64
   PubMed Web of Science ®Google Scholar
• Denny WA, Rewcastle GW, Baguly BC. Potential antitumor agents. 59. Structure-activity relationships for 2-phenylbenzimidazole-4-carboxamides, a new class of “minimal” DNA-intercalating agents which may not act via topoisomerase II. J Med Chem 1990;33:814–9
   PubMed Web of Science ®Google Scholar
• McKellar QA, Scott EW. The benzimidazole anthelmintic agents – a review. J Vet Pharmacol Ther 1990;13:223–47
   PubMed Web of Science ®Google Scholar
• Spasov AA, Yozhitsa IN, Bugaeva LI, Anisimova VA. Benzimidazole derivatives: spectrum of pharmacological activity and toxicological properties (a review). Pharm Chem J 1999;33:232–43
   Google Scholar
• Rossignol JF, Maisonneuve H. Benzimidazoles in the treatment of trichuriasis: a review. Ann Trop Med Parasitol 1984;78:135–44
   PubMed Web of Science ®Google Scholar
• Boiani M, Gonzalez M. Imidazole and benzimidazole derivatives as chemotherapeutic agents. Mini Rev Med Chem 2005;5:409–24
   PubMed Web of Science ®Google Scholar
• Desai GK, Desai RK. Green route for the heterocyclization of 2-mercaptobenzimidazole into beta-lactum segment derivatives containing -CONH- bridge with benzimidazole: screening in vitro antimicrobial activity with various microorganisms. Bioorg Med Chem Soc 2006;14:8271–9
   PubMed Web of Science ®Google Scholar
• Patil A, Ganguly S, Surana S. A systematic review of benzimidazole derivatives as an antiulcer agent. Rasayan J Chem 2008;1:447–60
   Google Scholar
• Dubey AK, Sanyal PK. Benzimidazoles in a Wormy World. Online Vet J 2010;5:63
   Google Scholar
• Narasimhan B, Sharma D, Kumar P. Benzimidazole: a medicinally important heterocyclic moiety. Med Chem Res 2012;21:269–83
   Web of Science ®Google Scholar
• Ramla MM, Omar MA, El-Khamry AM, El-Diwani HI. Synthesis and antitumor activity of 1-substituted-2-methyl-5-nitrobenzimidazoles. Bioorg Med Chem 2006;14:7324–32
   PubMed Web of Science ®Google Scholar
• El-NaemSh I, El-Nazhawy AO, El-Diwani HI, Abdel Hamid AO. Synthesis of 5-substituted 2-methylbenzimidazoles with anticancer activity. Arch Pharm 2003;336:7–17
   PubMed Web of Science ®Google Scholar
• Ng RA, Guan J, Alford VC, et al. 2-(2,2,2-Trifluoroethyl)-5,6-dichlorobenzimidazole derivatives as potent androgen receptor antagonists. Bioorg Med Chem Lett 2007;17:955–8
   PubMed Web of Science ®Google Scholar
• Omar MA, Shaker YM, Galal SA, et al. Synthesis and docking studies of novel antitumor benzimidazoles. Bioorg Med Chem 2012;20:6989–7001
   PubMed Web of Science ®Google Scholar
• Temirak A, Shaker YM, Ragab FAF, et al. Part I. Synthesis, biological evaluation and docking studies of novel 2-furylbenzimidazoles as anti-angiogenic agents. Eur J Med Chem 2014;1–13. (in press)
   Google Scholar
• Temirak A, Shaker YM, Ragab FAF, et al. Part II. Synthesis, biological evaluation and docking studies of new 2-furylbenzimidazoles as anti-angiogenic agents. Arch Pharm Chem Life Sci 2014;347:291–304
   PubMed Web of Science ®Google Scholar
• Tsay SC, Hwu JR, Singha R, et al. Coumarins hinged directly on benzimidazoles and their ribofuranosides to inhibit hepatitis C virus. Eur J Med Chem 2013;63:290–8
   PubMed Web of Science ®Google Scholar
• Li YF, Wang GF, Luo Y, et al. Identification of 1-isopropylsulfonyl-2-amine benzimidazoles as a new class of inhibitors of hepatitis B virus. Eur J Med Chem 2007;42:1358–64
   PubMed Web of Science ®Google Scholar
• Chodosh LA, Fire A, Samuels M, Sharp PA. 5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro. J Biol Chem 1989;264:2250–7
   PubMed Web of Science ®Google Scholar
• Townsend LB, Devivar RV, Turk SR, et al. Design, synthesis, and antiviral activity of certain 2,5,6-trihalo-1-(beta-D-ribofuranosyl)benzimidazoles. J Med Chem 1995;38:4098–105
   PubMed Web of Science ®Google Scholar
• Biron KK. Antiviral drugs for cytomegalovirus diseases. Antiviral Res 2006;71:154–63
   PubMed Web of Science ®Google Scholar
• Williams JD, Chen JJ, Drach JC, Townsend LB. Synthesis and antiviral activity of 3-formyl- and 3-cyano-2,5,6-trichloroindole nucleoside derivatives. J Med Chem 2004;47:5766–72
   PubMed Web of Science ®Google Scholar
• Andries K, Moeremans M, Gevers T, et al. Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus. Antiviral Res 2003;60:209–19
   PubMed Web of Science ®Google Scholar
• Hirashima S, Suzuki T, Ishida T, et al. Benzimidazole derivatives bearing substituted biphenyls as hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors: structure-activity relationship studies and identification of a potent and highly selective inhibitor JTK-109. J Med Chem 2006;49:4721–36
   PubMed Web of Science ®Google Scholar
• Hirashima S, Oka T, Ikegashira K, et al. Further studies on hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors toward improved replicon cell activities: benzimidazole and structurally related compounds bearing the 2-morpholinophenyl moiety. Bioorg Med Chem Lett 2007;17:3181–6
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63
   PubMed Web of Science ®Google Scholar
• Miura S, Yoshimura Y, Endo M, et al. Antitumor activity of a novel orally effective nucleoside, 1-(2-deoxy-2-fluoro-4-thio-β-d-arabinofuranosyl)cytosine. Cancer Lett 1998;129:103–10
   PubMed Web of Science ®Google Scholar
• Thabrew MI, Hughes RD, McFarlane IG. Screening of hepatoprotective plant components using a HepG2 cell cytotoxicity assay. J Pharm Pharmacol 1997;49:1132–5
   PubMed Web of Science ®Google Scholar
• Al-Rejaie SS, Aleisa AM, Al-Yahya AA, et al. Progression of diethylnitrosamine-induced hepatic carcinogenesis in carnitine-depleted rats. World J Gastroenterol 2009;15:1373–80
   PubMed Web of Science ®Google Scholar
• Prieur DJ, Young DM, Davis RD, et al. Procedures for preclinical toxicologic evaluation of cancer chemotherapeutic agents: protocols of the laboratory of toxicology. Cancer Chemother Rep 1973;4:1–28
   Google Scholar
• Ghosh MN. Fundamentals of experimental pharmacology. Calcutta, India: Scientific Book Agency; 1984:153–8
   Google Scholar
• Conn HJ, Darrow MA, Emmel VM, Staining procedure used by the biological stain commission. 2nd ed. Baltimore, MD: Williams & Wilkins Co.; 1960:289
   Google Scholar
• Simões CMO, Amoros M, Girre L. Mechanism of antiviral activity of triterpenoid saponins. Phytother Res 1999;13:323–8
   PubMed Web of Science ®Google Scholar
• Walum E, Stenberg K, Jenssen D. Understanding cell toxicology: principles and practice Ellis Horwood. J Appl Toxicol 1991;11:389–90
   Google Scholar
• Ramla MM, Omar MA, Tokuda H, El-Diwani HI. Synthesis and inhibitory activity of new benzimidazole derivatives against Burkitt's lymphoma promotion. Bioorg Med Chem 2007;15:6489–96
   PubMed Web of Science ®Google Scholar
• Holla BC, Akberali PM, Shivananda MK. Studies on nitrophenylfuran derivatives – part XII. Synthesis, characterization, antibacterial and antiviral activities of some nitrophenylfurfurylidene-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines. IL Farmaco 2001;56:919–27
   PubMedGoogle Scholar
• Turan-Zitouni G, Ozdemir A, Guven K. Synthesis of some 1-[(N,N-disubstituted thiocarbamoylthio)acetyl]-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives and investigation of their antibacterial and antifungal activities. Arch Pharm Chem Life Sci 2005;338:96–104
   PubMed Web of Science ®Google Scholar
• Turan-Zitouni G, Chevallet P, Kilic FS, Erol K. Synthesis of some thiazolyl-pyrazoline derivatives and preliminary investigation of their hypotensive activity. Eur J Med Chem 2000;35:635–41
   PubMed Web of Science ®Google Scholar
• Zampieri D, Mamolo MG, Laurini E, et al. Antifungal and antimycobacterial activity of 1-(3,5-diaryl-4,5-dihydro-1H-pyrazol-4-yl)-1H-imidazole derivatives. Bioorg Med Chem 2008;16:4516–22
   PubMed Web of Science ®Google Scholar
• Swenberg JA, Hoel DG, Magee PN. Mechanistic and statistical insight into the large carcinogenesis bioassays on N-nitrosodiethylamine and N-nitrosodimethylamine. Cancer Res 1991;51:6409–14
   PubMed Web of Science ®Google Scholar
• Anis KV, Rajeshkumar NV, Kuttan R. Inhibition of chemical carcinogenesis by berberine in rats and mice. J Pharm Pharmacol 2001;53:763–8
   PubMed Web of Science ®Google Scholar